Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Santen Oy
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Aged 18 years or more
A diagnosis of ocular hypertension or open-angle glaucoma and prior use of timolol or prostaglandin.
Meet specific IOP level at visit 1 (screening), visit 2 (run-in) and visit 3 (baseline).
Meet specific visual acuity score
Are willing to follow instructions
Have provided a written informed consent
You may not be if
Females who are pregnant, nursing or planning pregnancy
IOP of 35 mmHg or greater
Diagnosis of angle-closure glaucoma or secondary glaucoma other than capsular or pigmentary glaucoma in either eye
Suspected contraindication or hypersensitivity to study medications tafluprost or timolol (e.g. asthma, low pulse)or to wash-out medication brinzolamide
Glaucoma filtration surgery or any other ocular surgery (including ocular laser procedures) within 6 months prior to Screening
Use of contact lenses at Screening or during the study
Presence of any abnormality or significant illness that could be expected to interfere with the patient safety or study parameters
Current participation in another clinical trial within the last 30 days
Clareo Health | Tafluprost-Timolol Preservative-free Fixed Dose Combination (FDC) Superiority Study Against Monotherapies
